- April 22, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Aspi-Cor, Aspir-Low, Arthritis Pain, Aspir 81, Bufferin, Bayer Plus, Ecpirin, Durlaza, Ecotrin, Vazalore, Miniprin.
Synonyms :
Class :
Antiplatelet Agents, Hematologic; NSAIDs; Salicylates, Platelet aggregation inhibitors
Brand Name :
Aspi-Cor, Aspir-Low, Arthritis Pain, Aspir 81, Bufferin, Bayer Plus, Ecpirin, Durlaza, Ecotrin, Vazalore, Miniprin.
Synonyms :
Class :
Antiplatelet Agents, Hematologic; NSAIDs; Salicylates, Platelet aggregation inhibitors
Dosage Forms & Strengths
Tablet
81, 325, 500 mg
Tablet-delayed release
162, 325, 500 mg
Tablet-chewable
81mg
Tablet-enteric coated
81, 162, 325, 650mg
capsule, liquid filled
81, 325 mg
ER-capsule
162.5 mg
Initial dose: 325 mg-1 g every 4 hours 10 days as needed
Maximum dose: 4 g once a day
Do not exceed the dose of 4 gm a day
3
g
Orally
in divided doses as needed
3
g
oraly
in divided doses as needed
IR: 50-325 mg orally daily
ER: 162.5 mg orally daily
Prophylaxis
IR: 50-325 mg orally daily
ER: 162.5 mg orally daily
IR: 75-325 mg orally daily
ER: 162 mg orally daily
Prophylaxis
IR: 75-325 mg orally daily
ER: 162 mg orally daily
4 g orally daily in divided doses as needed
systemic Lupus Erythematosus (SLE)
3 g orally in divided doses as needed
Age: >50 years
75-100 mg orally daily
Dosage Forms & Strengths
Tablet
81, 325, 500 mg
Tablet-delayed release
162, 325, 500 mg
Tablet-chewable
81mg
Tablet-enteric coated
81, 162, 325, 650mg
capsule, liquid filled
81, 325 mg
ER-capsule
162.5 mg
Weight: <50 kg: 10-15 mg/kg orally every 4 times a day; maybe increase up to 60-80 mg/kg
Weight: ≥50 kg: 325-650 mg orally every 4 times a day; do not exceed 4 g a day
Weight: <25 kg: 60-100 mg/kg orally in divided doses as needed
Weight: ≥25 kg: 2.4-3.6 g orally a day
Initial: 80-100 mg/kg orally in divided doses 14 days
Maintenance: 3-6 mg/kg orally as a single dose daily
choline magnesium trisalicylate
NSAIDs may enhance the adverse/toxic effect of Salicylates
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may have an increased antiplatelet effect when combined with abrocitinib
may have an increasingly adverse effect when combined with apixaban
may have an increasingly adverse effect when combined with edoxaban
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
it may enhance the adverse/toxic effect of apixaban
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may increase the serum concentration of Lithium
NSAIDs may diminish the diuretic effect of loop diuretics
NSAIDs may diminish the diuretic effect of loop diuretics
NSAIDs may diminish the diuretic effect of loop diuretics
it may enhance the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
it may enhance the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
it may enhance the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
it may enhance the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
it may enhance the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
may increase the antiplatelet effect
may increase the anticoagulant effect of antiplatelet agents
may diminish the serum concentration when combined with aspirin
may have an increased anticoagulant effect when combined with Heparin
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)